Cannara Biotech (CNSX:LOVE) Director Donald John Olds Buys 25,000 Shares

Cannara Biotech (CNSX:LOVEGet Free Report) Director Donald John Olds acquired 25,000 shares of the stock in a transaction dated Tuesday, December 10th. The stock was acquired at an average cost of $0.78 per share, with a total value of $19,400.00.

Cannara Biotech Stock Performance

Cannara Biotech Company Profile

(Get Free Report)

Cannara Biotech Inc is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.

Featured Stories

Insider Buying and Selling by Quarter for Cannara Biotech (CNSX:LOVE)

Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.